Last update:

Cardiology news

Heart assembloids give researchers a new way to study heart valve disorders

A multidisciplinary, multi-institution group of researchers focused their expertise in genetics, mechanics, chemistry and biology on a chip the size of a postage stamp to model a particular class of heart conditions.

Balancing heart risk and surgical delays in complex preoperative care

In a new Annals "Beyond the Guidelines" feature, a general internal medicine physician and a cardiologist discuss how to evaluate and manage perioperative cardiovascular risk in an older patient with multiple chronic conditions ...

GLP-1 drug linked to heart benefits for high-risk patients

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart ...

Hemodialysis mortality risks by blood type

Do you know your blood type? It is important information used for blood transfusions, but few realize that blood types could also be linked to disease risks. In the general population, people with blood type O have been reported ...

Women with PMOS at four-fold higher risk of heart disease

Women with polyendocrine metabolic ovarian syndrome (PMOS; also known as polycystic ovary syndrome or PCOS) face a fourfold higher risk of heart disease than women without PMOS, according to a new nationwide U.S. study published ...

Two studies advance sudden cardiac arrest prediction

Warning symptoms, recurrent heart events may identify people at risk for this often-deadly event. Two studies from investigators at Cedars-Sinai Health Sciences University move the medical field closer to solving a longstanding ...

Drug hope for people with common heart thickening disease

A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease. The TEMPEST trial, led by University of Manchester researchers, tested the drug—called trientine—in 154 ...